|
Volumn 6, Issue 11, 2008, Pages 8-10
|
Future research directions for the treatment of AML.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4'-N-BENZOYLSTAUROSPORINE;
5 AZA 2' DEOXYCYTIDINE;
ANTINEOPLASTIC AGENT;
AZACITIDINE;
CARBAZOLE DERIVATIVE;
CARBOPLATIN;
CYTARABINE;
DAUNORUBICIN;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
ETOPOSIDE;
FLAVONOID;
FLAVOPIRIDOL;
LESTAURTINIB;
MIDOSTAURIN;
MITOXANTRONE;
PIPERIDINE DERIVATIVE;
QUINOLONE DERIVATIVE;
RETINOIC ACID;
STAUROSPORINE;
TIPIFARNIB;
TOPOTECAN;
ACUTE GRANULOCYTIC LEUKEMIA;
ARTICLE;
GENETICS;
HUMAN;
MEDICAL RESEARCH;
METABOLISM;
ANTINEOPLASTIC AGENTS;
AZACITIDINE;
BIOMEDICAL RESEARCH;
CARBAZOLES;
CARBOPLATIN;
CYTARABINE;
DAUNORUBICIN;
ENZYME INHIBITORS;
ETOPOSIDE;
FLAVONOIDS;
HUMANS;
LEUKEMIA, MYELOID, ACUTE;
MITOXANTRONE;
PIPERIDINES;
QUINOLONES;
STAUROSPORINE;
TOPOTECAN;
TRETINOIN;
|
EID: 61449107691
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|